S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)
S&P 500   4,604.37 (+0.41%)
DOW   36,247.87 (+0.36%)
QQQ   392.17 (+0.45%)
AAPL   195.71 (+0.74%)
MSFT   374.23 (+0.88%)
META   332.75 (+1.89%)
GOOGL   134.99 (-1.42%)
AMZN   147.42 (+0.37%)
TSLA   243.84 (+0.49%)
NVDA   475.06 (+1.95%)
NIO   7.39 (-1.34%)
BABA   72.16 (-0.24%)
AMD   128.92 (+0.43%)
T   16.92 (-0.99%)
F   11.01 (+1.76%)
MU   74.96 (+1.78%)
CGC   0.80 (+11.11%)
GE   120.59 (+0.93%)
DIS   92.82 (+0.84%)
AMC   6.93 (+1.61%)
PFE   28.78 (+0.52%)
PYPL   58.94 (+0.79%)
XOM   99.55 (+1.15%)

IRIDEX (IRIX) Earnings Date, Estimates & Call Transcripts

$2.76
+0.02 (+0.73%)
(As of 12/8/2023 ET)
Compare
Today's Range
$2.72
$2.80
50-Day Range
$1.90
$3.28
52-Week Range
$1.31
$3.48
Volume
39,286 shs
Average Volume
50,783 shs
Market Capitalization
$44.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00

Earnings Summary

Upcoming
Earnings Date
Mar. 14Estimated
Actual EPS
(Nov. 14)
-$0.11 Beat By $0.02
Consensus EPS
(Nov. 14)
-$0.13
Skip Charts & View Estimated and Actual Earnings Data

IRIX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IRIX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

IRIDEX Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.50) EPS
Next Year EPS Consensus Estimate: ($0.42) EPS

IRIX Earnings Date and Information

IRIDEX last released its quarterly earnings results on November 14th, 2023. The medical equipment provider reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.02. The firm had revenue of $12.85 million for the quarter, compared to the consensus estimate of $13.49 million. IRIDEX has generated ($0.48) earnings per share over the last year (($0.48) diluted earnings per share). Earnings for IRIDEX are expected to grow in the coming year, from ($0.50) to ($0.42) per share. IRIDEX has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off prior year's report dates.

IRIDEX Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/14/2024
Estimated)
------- 
11/14/2023Q3 2023($0.13)($0.11)+$0.02($0.11)$13.49 million$12.85 million
8/10/2023Q2 2023($0.11)($0.17)($0.06)($0.17)$14.23 million$12.86 million
5/11/2023Q1 2023($0.12)($0.13)($0.01)($0.13)$13.64 million$13.71 million
3/9/2023Q4 2022($0.11)($0.07)+$0.04($0.07)$15.17 million$15.20 million
11/10/2022Q3 2022($0.15)($0.11)+$0.04($0.11)$13.87 million$14.64 million
8/15/2022Q2 2022($0.16)($0.14)+$0.02($0.14)$13.93 million$13.76 million
5/12/2022Q1 2022($0.16)($0.15)+$0.01($0.15)$13.40 million$13.39 million
3/10/2022Q4 2021($0.11)($0.15)($0.04)($0.15)$15.18 million$15.25 million    
11/11/2021Q3 2021($0.15)($0.14)+$0.01($0.14)$11.90 million$13.26 million    
8/12/2021Q2 2021($0.16)($0.09)+$0.07($0.27)$11.61 million$13.43 million
5/11/2021Q1 2021($0.14)($0.14)-($0.14)$9.90 million$11.96 million  
3/21/2021Q4 2020($0.11)($0.01)+$0.10($0.01)$12.26 million$12.30 million  












IRIDEX Earnings - Frequently Asked Questions

When is IRIDEX's earnings date?

IRIDEX has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 14th, 2024 based off last year's report dates. Learn more on IRIX's earnings history.

Did IRIDEX beat their earnings estimates last quarter?

In the previous quarter, IRIDEX (NASDAQ:IRIX) reported ($0.11) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.13) by $0.02. Learn more on analysts' earnings estimate vs. IRIX's actual earnings.

How much revenue does IRIDEX generate each year?

IRIDEX (NASDAQ:IRIX) has a recorded annual revenue of $54.61 million.

How much profit does IRIDEX generate each year?

IRIDEX (NASDAQ:IRIX) has a recorded net income of -$7.55 million. IRIX has generated -$0.48 earnings per share over the last four quarters.

What is IRIDEX's EPS forecast for next year?

IRIDEX's earnings are expected to grow from ($0.50) per share to ($0.42) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:IRIX) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -